Announcements Trials
Browse Landscape

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 4Tumor-Agnostic 3Thoracic 2Other hematologic neoplasm 2Plasma cell 1Myeloid 1Head & Neck 1Classical hematology 1Breast 1

Conditions

Neoplasms 2Neoplasms, Second Primary 1

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Radiotherapy 47Capecitabine 47Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Registries × Tumor-Agnostic × Clear all
NCT04511806 2025-10-29

CCPS

Emory University

Recruiting
1,050 enrolled
Tumor-Agnostic

Neoplasms

NCT04376229 2025-07-01

Proton Radiation Therapy Registry

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Recruiting
5,000 enrolled
Tumor-Agnostic

Neoplasms, Second Primary

NCT02070328 2023-02-08

Registry

Center for Biomedical Research, LLC

Recruiting
300 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡